Clarified Precision Medicine
Porscha Johnson, PharmD, CPGx, currently serves as an Oncology Medical Science Liaison at Johnson & Johnson Innovative Medicine, focusing on precision medicine for non-small cell lung cancer. Porscha is the Executive Owner of PJW Clinical Pharmacy Consulting, LLC, where multiple consulting projects are managed, including medical writing and program development. As a Professional Mentor at Pharmacy Mentors, online mentoring for pharmacy professionals is provided. Porscha is also an Advisory Board Member on the Diversity, Equity, & Inclusion Task Force for the Hematology/Oncology Pharmacy Association. Additional roles include Expert Reviewer/Consultant for Clarified Precision Medicine and previous positions as a Lead Clinical Oncology Pharmacist at Northside Hospital. Educational credentials include a Doctor of Pharmacy from Howard University and studies at prestigious institutions such as Harvard Medical School.
This person is not in any teams
Clarified Precision Medicine
Clarified Precision Medicine is the first scalable molecular tumor board with a combination of AI-based platform plus medical group, offering expert clinical somatic and pharmacogenomics consultations through its ClarifiedSelect™ and OncoGuardian™ solutions. Clarified accelerates the delivery of guidelines-based genomic insights to patients and providers by bringing together nationally recognized experts in medical oncology, oncology pharmacy, data integration, and molecular pathology who have over 100 years of collective experience in the application of precision oncology. For more information, visit: www.clarifiedprecisionmedicine.com